Goldfarb Branham LLP is investigating whether the board of directors of American Medical Systems Holdings, Inc. (NASDAQ: AMMD) violated shareholder protection laws by agreeing to a buyout by Endo Pharmaceuticals for $30.00 per share. AMMD stockholders are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or email@example.com if they are interested in the impact of this acquisition on their shareholder rights. “Our investigation seeks to determine whether the process and price used by AMMD was fair to the shareholders under the circumstances,” securities lawyer Hamilton Lindley said. “This deal may be undervalued because AMMD earnings per share grew 14.3 percent more than last year. Our proposed class action lawsuit seeks to ensure that the buyout is fair to shareholders – both in terms of price and information.” Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. American Medical Systems investors – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-583-2855 to discuss their rights and remedies.